Literature DB >> 22035025

Nonmotor symptoms in Parkinson's disease.

Mark Stacy1.   

Abstract

The recognition and treatment of nonmotor symptoms are increasingly emphasized in the care of Parkinson's disease (PD) patients. This manuscript will review signs and symptoms localized, generally, to the cortex, basal ganglia, brainstem, spinal cord, and peripheral nervous system. Cortical manifestations include dementia, mild cognitive impairment, and psychosis. Apathy, restlessness (akathisia), and impulse control disorders will be linked as basal ganglia symptoms. Symptoms attributed to the brainstem comprise depression, anxiety, and sleep disorders. Peripheral nervous system disturbances may lead to orthostatic hypotension, constipation, pain, and sensory disturbances.

Entities:  

Mesh:

Year:  2011        PMID: 22035025     DOI: 10.3109/00207454.2011.620196

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  12 in total

1.  Mapping cortical atrophy in Parkinson's disease patients with dementia.

Authors:  Kristy S Hwang; Mona K Beyer; Amity E Green; Christine Chung; Paul M Thompson; Carmen Janvin; Jan P Larsen; Dag Aarsland; Liana G Apostolova
Journal:  J Parkinsons Dis       Date:  2013       Impact factor: 5.568

Review 2.  Neurodegenerative disorders and gut-brain interactions.

Authors:  Alpana Singh; Ted M Dawson; Subhash Kulkarni
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 19.456

Review 3.  Many Faces of Parkinson's Disease: Non-Motor Symptoms of Parkinson's Disease.

Authors:  Hye Mi Lee; Seong-Beom Koh
Journal:  J Mov Disord       Date:  2015-05-31

4.  The KMDS-NATION Study: Korean Movement Disorders Society Multicenter Assessment of Non-Motor Symptoms and Quality of Life in Parkinson's Disease NATION Study Group.

Authors:  Do Young Kwon; Seong Beom Koh; Jae Hyeok Lee; Hee Kyung Park; Han Joon Kim; Hae Won Shin; Jinyoung Youn; Kun Woo Park; Sun Ah Choi; Sang Jin Kim; Seong Min Choi; Ji Yun Park; Beom S Jeon; Ji Young Kim; Sun Ju Chung; Chong Sik Lee; Jeong Ho Park; Tae Beom Ahn; Won Chan Kim; Hyun Sook Kim; Sang Myung Cheon; Hee Tae Kim; Jee Young Lee; Ji Sun Kim; Eun Joo Kim; Jong Min Kim; Kwang Soo Lee; Joong Seok Kim; Min Jeong Kim; Jong Sam Baik; Ki Jong Park; Hee Jin Kim; Mee Young Park; Ji Hoon Kang; Sook Kun Song; Yong Duk Kim; Ji Young Yun; Ho Won Lee; Hyung Geun Oh; Jinwhan Cho; In Uk Song; Young H Sohn; Phil Hyu Lee; Jae Woo Kim
Journal:  J Clin Neurol       Date:  2016-10       Impact factor: 3.077

5.  The Alterations of Cortical Volume, Thickness, Surface, and Density in the Intermediate Sporadic Parkinson's Disease from the Han Population of Mainland China.

Authors:  Xia Deng; Meihong Zhou; Chunyan Tang; Jie Zhang; Lei Zhu; Zunchun Xie; Honghan Gong; Xiangzuo Xiao; Renshi Xu
Journal:  Front Aging Neurosci       Date:  2016-08-03       Impact factor: 5.750

Review 6.  Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments.

Authors:  Andrée-Anne Poirier; Benoit Aubé; Mélissa Côté; Nicolas Morin; Thérèse Di Paolo; Denis Soulet
Journal:  Parkinsons Dis       Date:  2016-12-06

Review 7.  T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.

Authors:  Javier Campos-Acuña; Daniela Elgueta; Rodrigo Pacheco
Journal:  Front Immunol       Date:  2019-02-15       Impact factor: 7.561

8.  Brain-derived neurotrophic factor serum levels correlate with cognitive performance in Parkinson's disease patients with mild cognitive impairment.

Authors:  Alberto Costa; Antonella Peppe; Giovanni Augusto Carlesimo; Silvia Zabberoni; Francesco Scalici; Carlo Caltagirone; Francesco Angelucci
Journal:  Front Behav Neurosci       Date:  2015-09-15       Impact factor: 3.558

Review 9.  Role of MicroRNAs in Parkinson's Disease.

Authors:  Suh Yee Goh; Yin Xia Chao; Shaikali Thameem Dheen; Eng-King Tan; Samuel Sam-Wah Tay
Journal:  Int J Mol Sci       Date:  2019-11-12       Impact factor: 5.923

Review 10.  Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease.

Authors:  Carroll Rutherford Fields; Nora Bengoa-Vergniory; Richard Wade-Martins
Journal:  Front Mol Neurosci       Date:  2019-12-05       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.